Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK561679 for PTSD and Sleep Disturbances in Women
NCT01814332Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2010
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
A Phase 2 trial of verucerfont in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Jan 2010; status: completed.
02
Drugs
verucerfont
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01814332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814332.